References
- Brun C., Hilden T., Raaschou F. The significance of the difference in systemic arterial and venous plasma concentrations in renal clearance methods. Journal of Clinical Investigation 1949; 28: 144–152
- Cummings A. J. A survey of pharmacokinetic data from pregnant women. Clinical Pharmacokinetics 1983; 8: 344–354
- Heusse D., Decouvelare B., Kaye C., Thomas R. Les especes animales et le metabolisme. Inserm 1980; 96: 347–362
- Hughes M. A., Meredith P. A., Elliott H. L. The determination of trimazosin and its metabolite CP23445 in whole blood by high performance liquid chromatography using fluorescence detection. Journal of Pharmacological Methods 1984; 12: 167–172
- Juchau M. R. Drug biotransformation in the placenta. Pharmacology and Therapeutics 1980; 8: 501–524
- Lam G., Chiou W. L. Determination of renal clearances using arterial and venous plasma: procainamide in rabbits. Journal of Pharmaceutical Science 1981; 70: 1373–1375
- Lefebvre M. A., Girault J., Fourtillan J. B. Beta-blocking agents: Determination of biological levels using high performance liquid chromatography. Journal of Liquid Chromstography 1981; 4: 483–500
- Lloyd-Jones J. G., Henson R. A., Nichols J. D., Greenslade D., Clifford J. M. Pharmacokinetics of intravenous and oral tolmesoxide. European J ournal of Clinical Pharmacology 1981; 19: 119–125
- Martin E., Moll W., Schmid P., Detti L. The pharmacokinetics of alcohol in human breath, venous and arterial blood after oral ingestion. European Journal of Clinical Pharmacology 1984; 26: 619–626
- Vincent J., Elliott H. L., Meredith P., Reid J. L. Trimazosin: relationships between hypotensive effects, vascular responsiveness and drug and metabolite concentrations. Journal of Cardiovascular Pharmacology 1985; 7: 913–918